BDR Pharma Gets DRDO Nod To Manufacture, Sell Covid Drug 2-DG In India
BDR Pharma on Monday said it has inked a licensing pact with the Defence Research and Development Organisation (DRDO) to manufacture, distribute, and market COVID-19 drug 2-Deoxy-D-Glucose (2-DG) in...
from NDTV News - Latest https://ift.tt/3iRNNvX
via IFTTT
from NDTV News - Latest https://ift.tt/3iRNNvX
via IFTTT
Comments
Post a Comment